The Schizophrenia Cognition Rating Scale: an interview-based assessment and its relationship to cognition, real-world functioning, and functional capacity.
about
Functional capacity: a new framework for the assessment of everyday functioning in schizophreniaHospitalization and psychosis: influences on the course of cognition and everyday functioning in people with schizophreniaReliability, validity and treatment sensitivity of the Schizophrenia Cognition Rating Scale.A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophreniaAltered resting-state EEG source functional connectivity in schizophrenia: the effect of illness duration.Anticipating DSM-V: opportunities and challenges for cognition and psychosisEvidence for an immune role on cognition in schizophrenia: a systematic reviewThe use of narrative sampling in the assessment of social cognition: the Narrative of Emotions Task (NET).Initial development of a patient-reported outcome measure of experience with cognitive impairment associated with schizophrenia.Common and specific cognitive deficits in schizophrenia: relationships to function.Enhancing and Promoting Recovery In Attentionally Impaired People Diagnosed With Schizophrenia: Results From A Randomized Controlled Trial Of Attention Shaping In A Partial Hospital Program.Towards a framework for treatment effectiveness in schizophrenia.A randomized, controlled trial of Social Cognition and Interaction Training (SCIT) for outpatients with schizophrenia spectrum disorders.The clinical utility of lurasidone in schizophrenia: patient considerationsRandomized, Double-Blind, Placebo-Controlled Study of Encenicline, an α7 Nicotinic Acetylcholine Receptor Agonist, as a Treatment for Cognitive Impairment in SchizophreniaQuetiapine versus aripiprazole in children and adolescents with psychosis--protocol for the randomised, blinded clinical Tolerability and Efficacy of Antipsychotics (TEA) trialThe α7 Nicotinic Agonist ABT-126 in the Treatment of Cognitive Impairment Associated with Schizophrenia in Nonsmokers: Results from a Randomized Controlled Phase 2b Study.Validating measures of real-world outcome: the results of the VALERO expert survey and RAND panelCognitive training plus a comprehensive psychosocial programme (OPUS) versus the comprehensive psychosocial programme alone for patients with first-episode schizophrenia (the NEUROCOM trial): a study protocol for a centrally randomised, observer-bliEfficacy of amisulpride and olanzapine for negative symptoms and cognitive impairments: An open-label clinical studyFactors influencing self-assessment of cognition and functioning in schizophrenia: implications for treatment studies.The FOCUS trial: cognitive remediation plus standard treatment versus standard treatment for patients at ultra-high risk for psychosis: study protocol for a randomised controlled trialHippocampal subfield volumes in first episode and chronic schizophrenia.Subjective cognitive complaints in schizophrenia: relation to antipsychotic medication dose, actual cognitive performance, insight and symptomsSubjective and Objective Cognitive Dysfunction in Schizophrenia - is there a Link?Assessing everyday functioning in schizophrenia: not all informants seem equally informativeObservable Social Cognition--A Rating Scale: an interview-based assessment for schizophreniaBifactor and item response theory analyses of interviewer report scales of cognitive impairment in schizophrenia.The Cognitive Assessment Interview (CAI): development and validation of an empirically derived, brief interview-based measure of cognitionThe FDA-NIMH-MATRICS guidelines for clinical trial design of cognitive-enhancing drugs: what do we know 5 years later?Assessment of Lifespan Functioning Attainment (ALFA) scale: A quantitative interview for self-reported current and functional decline in schizophrenia.The effects of aging on insight into illness in schizophrenia: a review.Quantifying clinical relevance in the treatment of schizophrenia.Differential patterns of blood oxygenation in the prefrontal cortex between patients with methamphetamine-induced psychosis and schizophrenia.The cultural adaptability of intermediate measures of functional outcome in schizophreniaNeuropsychiatric screening in type 2 diabetes mellitus.Enhancing assertive community treatment with cognitive behavioral social skills training for schizophrenia: study protocol for a randomized controlled trial.The Chinese Version of the Brief Assessment of Cognition in Schizophrenia: Data of a Large-Scale Mandarin-Speaking Population.Report on ISCTM Consensus Meeting on Clinical Assessment of Response to Treatment of Cognitive Impairment in SchizophreniaNeurocognitive insight and objective cognitive functioning in schizophrenia
P2860
Q26786322-F4B683EE-D577-4BB1-919A-57AE42DFC51AQ26995247-CE0A5980-83F7-470C-9CCA-34801F9BE73DQ27311539-82FF831E-996B-4748-A769-EE6F4F82B3F9Q30498769-8D9BCD7A-6C44-409C-8EE9-69B16D63080DQ30647676-FC3DA3E9-B214-41B2-9287-041F867DF19BQ33566164-323000CA-F928-465F-97FF-8698EC022923Q33621692-C6473425-4915-4AB6-AF42-BC9D9876353BQ33699771-5D4DA7B3-1F56-4218-96DB-4F885FBD34BFQ33813268-60C22AF1-E498-4BFE-94E5-8D9F64B04A29Q33851041-BACD1312-6476-43FD-87C8-85AE3D3F4C6EQ34240684-0A23DFFB-5159-46E3-9B10-3EF455E26822Q34274631-F17AD1C7-7EF4-4E4C-A4E1-A11AF33FF91CQ34397475-8E2CBA07-A7AD-4B3F-BFE2-7F00C14DDD42Q34477219-0F805FD1-DDCC-4CC7-B77F-1F8A63D04503Q34481351-552AFC7A-4FCC-4B51-93D0-A2A727C8560BQ34486230-60ED8AA6-423F-4682-B510-A2074EFCA09AQ34531316-6035F176-E3FB-43BA-BABE-1D37FB9D0154Q34604227-67C7BA35-4735-4059-913A-CB8E1204B980Q34615766-414CC7AD-7EAE-461B-9206-C860130FFA34Q34665354-D26F7C3E-323B-4F85-BFFA-EAA0F7BEBDF8Q35009716-29858461-AC9A-4DF0-AA19-C982BA6F0D64Q35052697-3C35DE64-2A6D-4975-AEC1-F1EBFF520A2DQ35058064-B4EE4A24-7F44-4D9A-8E25-9A52D6000FAEQ35078190-E64B11AF-91F5-4E02-837B-4102A4E74CA9Q35091697-077D7677-2FBD-4BF2-A97D-FC8F1AA86E44Q35175794-AA1EF55A-A23D-461B-B94D-7A46B41F5DC3Q35214074-33D55622-76D3-43B0-942A-84ED85D053EBQ35245833-D3EA8B0B-C73B-4AB5-A29B-4F1BE7EBB550Q35252491-122B412C-9187-47A5-AF98-F9E64303404AQ35390239-882F7AC3-2235-4344-879E-12339E86F107Q35629742-746F6332-24F9-42EA-B6C4-9EA1BBF9F431Q35756601-C79B22F3-797A-4250-8EC4-F6ECCF948B7AQ35819467-1EE0665A-3EF8-4F8F-BB7B-77A51042B423Q35856493-195E0418-1E44-46C3-B3E2-2110BBFF1C3FQ35898719-51026F30-DE96-4A0B-899A-4595C38CB77AQ35968120-CBCB3979-223A-4B6E-BED3-E4125ADA1774Q36111859-07C83354-7E0A-4ACD-881A-07603A642F48Q36353635-2936F77A-B3C3-4E49-937B-AD0AB7ED9727Q36377916-203FCE70-5A15-467E-8F29-F3CF141DE392Q36604658-6CE5752B-80A5-4E73-84F5-583C5829EAFD
P2860
The Schizophrenia Cognition Rating Scale: an interview-based assessment and its relationship to cognition, real-world functioning, and functional capacity.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
The Schizophrenia Cognition Ra ...... ning, and functional capacity.
@ast
The Schizophrenia Cognition Ra ...... ning, and functional capacity.
@en
The Schizophrenia Cognition Ra ...... ning, and functional capacity.
@nl
type
label
The Schizophrenia Cognition Ra ...... ning, and functional capacity.
@ast
The Schizophrenia Cognition Ra ...... ning, and functional capacity.
@en
The Schizophrenia Cognition Ra ...... ning, and functional capacity.
@nl
prefLabel
The Schizophrenia Cognition Ra ...... ning, and functional capacity.
@ast
The Schizophrenia Cognition Ra ...... ning, and functional capacity.
@en
The Schizophrenia Cognition Ra ...... ning, and functional capacity.
@nl
P2093
P1476
The Schizophrenia Cognition Ra ...... ning, and functional capacity.
@en
P2093
Joseph W Kang
Margaret Poe
Richard S E Keefe
Trina M Walker
P304
P356
10.1176/APPI.AJP.163.3.426
P407
P577
2006-03-01T00:00:00Z